Table 1 Demographic and clinical characteristics of study groups.

From: Cannabinoid 1 receptor availability in posttraumatic stress disorder: A positron emission tomography study

 

HCs

TCs

PTSD

  
 

16

27

19

  

N

M (s.d.) or n (%)

M (s.d.) or n (%)

M (s.d.) or n (%)

Test of difference

Pairwise comparisons

Age

29.37 (8.16)

45.78 (13.90)

42.58 (13.03)

F(2,59) = 9.14, P = 0.001

HC < TC, PTSD

Male sex

9 (56.25%)

25 (92.6%)

10 (52.63%)

χ2(2) = 10.91, P = 0.004

TC > HC, PTSD

Veteran (yes)

0 (0%)

24

11

χ2(2) = 32.31, P = 0.001

 

White race/ethnicity

10 (62.5%)

22 (81.5%)

16 (84.2%)

χ2(2) = 3.66, P = 0.16 NS

 

Body mass index

25.76 (4.88)

29.74 (6.04)

30.133 (5.79)

F(2,59) = 3.17, P = 0.049

HC < TC, PTSD

Indices of criteria: A lifetime trauma

Age at first trauma

N/A

n = 21 16.52 (7.1)

n = 10 14.3 (7.96)

T(16) = 0.75,p = 0.46 NS

 

Age at presenting trauma

N/A

n = 24 29.4 (9.37)

n = 18 22.65 (14.6)

T(25) = 1.59, p = 0.12 NS

 

Number of traumas

0

n = 24 5.29 (3.3)

n = 11 27.64 (32.5)

T(10) = 2.27, p < 0.045

 

Index traumatic event (n)

 

24

18

  

Military trauma

0

20

9

  

Physical assault

0

1

9

  

Motor vehicle accident

0

2

0

  

Witnessed suicide

0

1

0

  

Total number of current psychiatric diagnoses (not including PTSD)

0

n = 24 0.42 (0.58)

N = 19 2 (1.41)

  

CAPS-5 score

8.72 (6.91)

38.42 (9.34)

T(29) = 11.26, p < 0.001

PTSD > TC

Injected mass

13.71 (3.85)

14.22 (3.34)

12.05 (4.83)

F(2,59) = 1.85, P = 0.17 NS